This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Asahi Kasei Pharma Corporation, Raqualia Pharma Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021-2025
Title: Toshihiko Sone: Innovator in Pharmaceutical Chemistry
Introduction
Toshihiko Sone is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 3 patents to his name, Sone's work has the potential to impact various medical treatments.
Latest Patents
One of Sone's latest patents involves tetrahydroquinoline derivatives as P2X7 receptor antagonists. This invention relates to tetrahydroquinoline derivatives or their pharmaceutically acceptable salts or prodrugs. The patent outlines processes for their preparation, pharmaceutical compositions containing these compounds, and their use in treating disorders mediated via the P2X7 receptor. This innovative approach could lead to new therapeutic options for patients suffering from related conditions.
Career Highlights
Throughout his career, Toshihiko Sone has worked with notable companies in the pharmaceutical industry. He has been associated with Raqualia Pharma Inc. and Asahi Kasei Pharma Corporation, where he has contributed to various research and development projects. His expertise in pharmaceutical chemistry has been instrumental in advancing the field.
Collaborations
Sone has collaborated with several professionals in his field, including Yoshimasa Arano and Kazuki Toyoshima. These collaborations have fostered innovation and have led to the development of new therapeutic strategies.
Conclusion
Toshihiko Sone is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile